Skip to main content

Research and statistics

Skip to results
337 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Monthly counts of Escherichia coli (E.coli) bacteraemia by organisation and location of onset (from April 2019).

  • Monthly counts of meticillin-susceptible Staphylococcus aureus (MSSA) bacteraemia by organisation and location of onset (from April 2019).

  • Monthly counts of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by organisation and location of onset (from April 2019).

  • Monthly counts of Clostridioides difficile (C. difficile) infections by NHS organisation and prior trust exposure (from April 2019) in patients aged 2 years and over.

  • Monthly counts of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia by organisation and location of onset (from April 2019).

  • Monthly counts of Klebsiella species (Klebsiella spp.) bacteraemia by organisation and location of onset (from April 2019).

  • UK quarterly data and commentary on coverage achieved by the UK childhood immunisation programme.

  • Epidemiological, microbiological and food chain investigation summary about an outbreak of Shiga toxin-producing Escherichia coli (STEC) O145.

  • Modelled proportion of the population (prevalence) in England and Scotland currently infected with SARS-CoV-2 (COVID-19), incidence of new infections, the infection hospitalisation rate (IHR) and the infection fatality risk …

  • A yearly overview of influenza surveillance results from the winter period.

  • These reports detail high consequence infectious disease (HCID) events that are detected during UKHSA's epidemic intelligence activities.

  • UKHSA publishes overviews each year of influenza surveillance results from the winter period.

  • The UK Health Security Agency (UKHSA) collects and publishes statistics related to planning, preventing and responding to external health threats.

  • Analysis and learning from radiotherapy and near miss data reported voluntarily by UK radiotherapy providers and the relevant reporting authorities.

  • Risk assessments on the investigation into the risk to human health of avian influenza (influenza A H5N1) in England.

  • Risk review and statement on the zoonotic risk avian influenza A(H5N1) clade 2.3.4.4b genotype B3.13 presents to people in contact with infected animals in the UK

  • Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.

  • Updates on new or emerging infectious disease events that could affect UK public health.

  • Uptake of the seasonal influenza vaccine in frontline healthcare workers during the 2023 to 2024 influenza vaccination programme in England.

  • Report on the uptake of influenza vaccine in children of school age during the 2023 to 2024 influenza vaccination programme in England.